ARCT CIK: 1768224

Arcturus Therapeutics Holdings Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−203
FY22:
12.2
FY23:
−78.2
FY24:
−95.7
FY25:
−76.3
(positive)
millions USD
FY21:
−202
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−204
FY22:
10.6
FY23:
−27.9
FY24:
−80.9
FY25:
−65.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−204
FY22:
9.35
FY23:
−29.7
FY24:
−80.9
FY25:
−65.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data